CoChat
Sign Up
Cited by 60

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Oxysterols present in Alzheimer's disease brain induce synaptotoxicity by activating astrocytes: A major role for lipocalin-2

Staurenghi, Erica, Cerrato, Valentina, Gamba, Paola, Testa, Gabriella, Giannelli, Serena, Leoni, Valerio, Caccia, Claudio, Buffo, Annalisa, Noble, Wendy, Perez-Nievas, Beatriz Gomez, Leonarduzzi, Gabriella·2021·Redox Biology
DOI 10.1016/j.redox.2020.101837PMC PMC7772793
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.redox.2020.101837

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 76

  1. Prince, 2015, World alzheimer report 2015: the global impact of dementia: an analysis of prevalence, incidence, cost and trends, Alzheimer’s Disease International
  2. Lane, 2018, Alzheimer's disease, Eur. J. Neurol., 25, 59, 10.1111/ene.13439 · DOI · Paper page
  3. Perez-Nievas, 2018, Deciphering the astrocyte reaction in Alzheimer’s disease, Front. Aging Neurosci., 10, 114, 10.3389/fnagi.2018.00114 · DOI · Paper page
  4. Anderson, 2014, Heterogeneity of reactive astrocytes, Neurosci. Lett., 565, 23, 10.1016/j.neulet.2013.12.030 · DOI
  5. Zamanian, 2012, Genomic analysis of reactive astrogliosis, J. Neurosci., 32, 6391, 10.1523/JNEUROSCI.6221-11.2012 · DOI · Paper page
  6. Iram, 2016, Astrocytes from old Alzheimer's disease mice are impaired in Abeta uptake and in neuroprotection, Neurobiol. Dis., 96, 84, 10.1016/j.nbd.2016.08.001 · DOI
  7. Garwood, 2011, Astrocytes are important mediators of Abeta-induced neurotoxicity and tau phosphorylation in primary culture, Cell Death Dis., 2, e167, 10.1038/cddis.2011.50 · DOI · Paper page
  8. Cavanagh, 2016, Inhibiting tumor necrosis factor-alpha before amyloidosis prevents synaptic deficits in an Alzheimer's disease model, Neurobiol. Aging, 47, 41, 10.1016/j.neurobiolaging.2016.07.009 · DOI · Paper page
  9. Naude, 2012, Lipocalin 2: novel component of proinflammatory signaling in Alzheimer’s disease, FASEB J., 26, 2811, 10.1096/fj.11-202457 · DOI
  10. Ferreira, 2015, From the periphery to the brain: lipocalin-2, a friend or foe?, Prog. Neurobiol., 131, 120, 10.1016/j.pneurobio.2015.06.005 · DOI
  11. Bi, 2013, Reactive astrocytes secrete lcn2 to promote neuron death, Proc. Natl. Acad. Sci. U. S. A., 110, 4069, 10.1073/pnas.1218497110 · DOI · Paper page
  12. Alzheimer, 1995, An English translation of Alzheimer's 1907 paper, Uber eine eigenartige Erkankung der Hirnrinde, Clin. Anat., 8, 429, 10.1002/ca.980080612 · DOI · Paper page
  13. Corder, 1993, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, 261, 921, 10.1126/science.8346443 · DOI · Paper page
  14. Wood, 2014, Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis, J. Neurochem., 129, 559, 10.1111/jnc.12637 · DOI · Paper page
  15. Gamba, 2015, Oxidized cholesterol as the driving force behind the development of Alzheimer's disease, Front. Aging Neurosci., 7, 10.3389/fnagi.2015.00119 · DOI · Paper page
  16. Dason, 2014, Cholesterol and F-actin are required for clustering of recycling synaptic vesicle proteins in the presynaptic plasma membrane, J Physiol, 592, 621, 10.1113/jphysiol.2013.265447 · DOI
  17. van Deijk, 2017, Astrocyte lipid metabolism is critical for synapse development and function in vivo, Glia, 65, 670, 10.1002/glia.23120 · DOI · Paper page
  18. Gilardi, 2009, Expression of sterol 27-hydroxylase in glial cells and its regulation by liver X receptor signaling, Neuroscience, 164, 530, 10.1016/j.neuroscience.2009.08.003 · DOI
  19. Iuliano, 2015, Cholesterol metabolites exported from human brain, Steroids, 99, 189, 10.1016/j.steroids.2015.01.026 · DOI
  20. Testa, 2016, Changes in brain oxysterols at different stages of Alzheimer's disease: their involvement in neuroinflammation, Redox Biol, 10, 24, 10.1016/j.redox.2016.09.001 · DOI · Paper page
  21. Mutemberezi, 2016, Oxysterols: from cholesterol metabolites to key mediators, Prog. Lipid Res., 64, 152, 10.1016/j.plipres.2016.09.002 · DOI
  22. Zarrouk, 2014, Involvement of oxysterols in age-related diseases and ageing processes, Ageing Res. Rev., 18, 148, 10.1016/j.arr.2014.09.006 · DOI
  23. Testa, 2014, Loading into nanoparticles improves quercetin's efficacy in preventing neuroinflammation induced by oxysterols, PloS One, 9, 10.1371/journal.pone.0096795 · DOI
  24. Zhang, 2019, 27-hydroxycholesterol promotes Abeta accumulation via altering Abeta metabolism in mild cognitive impairment patients and APP/PS1 mice, Brain Pathol., 29, 558, 10.1111/bpa.12698 · DOI
  25. Gamba, 2011, Interaction between 24-hydroxycholesterol, oxidative stress, and amyloid-beta in amplifying neuronal damage in Alzheimer's disease: three partners in crime, Aging Cell, 10, 403, 10.1111/j.1474-9726.2011.00681.x · DOI
  26. Marwarha, 2010, Leptin reduces the accumulation of Abeta and phosphorylated tau induced by 27-hydroxycholesterol in rabbit organotypic slices, J. Alzheimers Dis., 19, 1007, 10.3233/JAD-2010-1298 · DOI
  27. Merino-Serrais, 2019, 27-Hydroxycholesterol induces aberrant morphology and synaptic dysfunction in hippocampal neurons, Cerebr. Cortex, 29, 429, 10.1093/cercor/bhy274 · DOI
  28. Jang, 2011, 7-ketocholesterol induces apoptosis in differentiated PC12 cells via reactive oxygen species-dependent activation of NF-kappaB and Akt pathways, Neurochem. Int., 58, 52, 10.1016/j.neuint.2010.10.012 · DOI
  29. Nury, 2013, Improved synthesis and in vitro evaluation of the cytotoxic profile of oxysterols oxidized at C4 (4alpha- and 4beta-hydroxycholesterol) and C7 (7-ketocholesterol, 7alpha- and 7beta-hydroxycholesterol) on cells of the central nervous system, Eur. J. Med. Chem., 70, 558, 10.1016/j.ejmech.2013.09.028 · DOI
  30. An, 2017, 27-Hydroxycholesterol regulates cholesterol synthesis and transport in C6 glioma cells, Neurotoxicology, 59, 88, 10.1016/j.neuro.2017.02.001 · DOI
  31. Abildayeva, 2006, 24(S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux, J. Biol. Chem., 281, 12799, 10.1074/jbc.M601019200 · DOI · Paper page
  32. Ma, 2015, The oxysterol 27-hydroxycholesterol increases oxidative stress and regulate Nrf2 signaling pathway in astrocyte cells, Neurochem. Res., 40, 758, 10.1007/s11064-015-1524-2 · DOI
  33. Cigliano, 2019, 24S-hydroxycholesterol affects redox homeostasis in human glial U-87MG cells, Mol. Cell. Endocrinol., 486, 25, 10.1016/j.mce.2019.02.013 · DOI
  34. Bochelen, 2000, 7beta-hydroxysterol is cytotoxic to neonatal rat astrocytes in primary culture when cAMP levels are increased, J. Neurosci. Res., 62, 99, 10.1002/1097-4547(20001001)62:1<99::AID-JNR11>3.0.CO;2-2 · DOI
  35. Schildge, 2013, Isolation and culture of mouse cortical astrocytes, JoVE, 71
  36. Hudry, 2012, Inhibition of the NFAT pathway alleviates amyloid beta neurotoxicity in a mouse model of Alzheimer's disease, J. Neurosci., 32, 3176, 10.1523/JNEUROSCI.6439-11.2012 · DOI
  37. Leoni, 2012, Metabolic consequences of mitochondrial coenzyme A deficiency in patients with PANK2 mutations, Mol. Genet. Metabol., 105, 463, 10.1016/j.ymgme.2011.12.005 · DOI
  38. Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods, 25, 402, 10.1006/meth.2001.1262 · DOI · Paper page
  39. Sovrea, 2013, Astrocytes reassessment - an evolving concept part one: embryology, biology, morphology and reactivity, J. Mol. Psychiatry, 1, 18, 10.1186/2049-9256-1-18 · DOI
  40. Liddelow, 2017, Reactive astrocytes: production, function, and therapeutic potential, Immunity, 46, 957, 10.1016/j.immuni.2017.06.006 · DOI · Paper page
  41. Sofroniew, 2014, Multiple roles for astrocytes as effectors of cytokines and inflammatory mediators, Neuroscientist, 20, 160, 10.1177/1073858413504466 · DOI · Paper page
  42. Kim, 2017, Astrocyte-derived lipocalin-2 mediates hippocampal damage and cognitive deficits in experimental models of vascular dementia, Glia, 65, 1471, 10.1002/glia.23174 · DOI
  43. Lordan, 2009, Oxysterols and mechanisms of apoptotic signaling: implications in the pathology of degenerative diseases, J. Nutr. Biochem., 20, 321, 10.1016/j.jnutbio.2009.01.001 · DOI
  44. D'Amelio, 2012, Caspase-3 in the central nervous system: beyond apoptosis, Trends Neurosci., 35, 700, 10.1016/j.tins.2012.06.004 · DOI
  45. Mucha, 2011, Lipocalin-2 controls neuronal excitability and anxiety by regulating dendritic spine formation and maturation, Proc. Natl. Acad. Sci. U. S. A., 108, 18436, 10.1073/pnas.1107936108 · DOI
  46. Lee, 2012, Regulation by lipocalin-2 of neuronal cell death, migration, and morphology, J. Neurosci. Res., 90, 540, 10.1002/jnr.22779 · DOI
  47. Karch, 2015, Alzheimer's disease risk genes and mechanisms of disease pathogenesis, Biol. Psychiatr., 77, 43, 10.1016/j.biopsych.2014.05.006 · DOI · Paper page
  48. Boisvert, 2018, The aging astrocyte transcriptome from multiple regions of the mouse brain, Cell Rep., 22, 269, 10.1016/j.celrep.2017.12.039 · DOI · Paper page
  49. Lee, 2009, Lipocalin-2 is an autocrine mediator of reactive astrocytosis, J. Neurosci., 29, 234, 10.1523/JNEUROSCI.5273-08.2009 · DOI
  50. Holtje, 2005, Role of Rho GTPase in astrocyte morphology and migratory response during in vitro wound healing, J. Neurochem., 95, 1237, 10.1111/j.1471-4159.2005.03443.x · DOI · Paper page
  51. Dekens, 2020, Iron chelators inhibit amyloid-beta-induced production of lipocalin 2 in cultured astrocytes, Neurochem. Int., 132, 104607, 10.1016/j.neuint.2019.104607 · DOI
  52. Styren, 1998, Expression of differential immune factors in temporal cortex and cerebellum: the role of alpha-1-antichymotrypsin, apolipoprotein E, and reactive glia in the progression of Alzheimer's disease, J. Comp. Neurol., 396, 511, 10.1002/(SICI)1096-9861(19980713)396:4<511::AID-CNE7>3.0.CO;2-4 · DOI
  53. Rutkowska, 2018, EBI2 regulates pro-inflammatory signalling and cytokine release in astrocytes, Neuropharmacology, 133, 121, 10.1016/j.neuropharm.2018.01.029 · DOI
  54. Mutemberezi, 2018, Oxysterol levels and metabolism in the course of neuroinflammation: insights from in vitro and in vivo models, J. Neuroinflammation, 15, 74, 10.1186/s12974-018-1114-8 · DOI
  55. van Gijsel-Bonnello, 2017, Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer's disease: alleviation by pantethine, PloS One, 12, 10.1371/journal.pone.0175369 · DOI · Paper page
  56. Choi, 2014, Human astrocytes: secretome profiles of cytokines and chemokines, PloS One, 9, 10.1371/journal.pone.0092325 · DOI
  57. Sharma, 2007, Modulation of interleukin-1beta mediated inflammatory response in human astrocytes by flavonoids: implications in neuroprotection, Brain Res. Bull., 73, 55, 10.1016/j.brainresbull.2007.01.016 · DOI · Paper page
  58. Hubbard, 2000, Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades, Free Radic. Biol. Med., 28, 1379, 10.1016/S0891-5849(00)00223-9 · DOI
  59. Lyons, 1998, Cleavage of membrane-associated ICAM-1 from astrocytes: involvement of a metalloprotease, Glia, 22, 103, 10.1002/(SICI)1098-1136(199802)22:2<103::AID-GLIA1>3.0.CO;2-8 · DOI
  60. Trombetta, 2018, The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer's disease, PloS One, 13, 10.1371/journal.pone.0193707 · DOI
  61. Janelidze, 2018, CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease, Neurology, 91, e867, 10.1212/WNL.0000000000006082 · DOI · Paper page
  62. Allaman, 2010, Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability, J. Neurosci., 30, 3326, 10.1523/JNEUROSCI.5098-09.2010 · DOI
  63. Sheng, 2001, The postsynaptic NMDA-receptor--PSD-95 signaling complex in excitatory synapses of the brain, J. Cell Sci., 114, 1251, 10.1242/jcs.114.7.1251 · DOI
  64. Prieto, 2017, Cytokines and cytokine networks target neurons to modulate long-term potentiation, Cytokine Growth Factor Rev., 34, 27, 10.1016/j.cytogfr.2017.03.005 · DOI
  65. Turner, 2014, Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease, Biochim. Biophys. Acta, 1843, 2563, 10.1016/j.bbamcr.2014.05.014 · DOI
  66. Mao, 2016, Synaptically localized mitogen-activated protein kinases: local substrates and regulation, Mol. Neurobiol., 53, 6309, 10.1007/s12035-015-9535-1 · DOI
  67. Paul, 2013, The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors, J. Neurosci., 33, 17290, 10.1523/JNEUROSCI.2619-13.2013 · DOI
  68. Kulig, 2016, Cholesterol oxidation products and their biological importance, Chem. Phys. Lipids, 199, 144, 10.1016/j.chemphyslip.2016.03.001 · DOI
  69. Dias, 2019, Localisation of oxysterols at the sub-cellular level and in biological fluids, J. Steroid Biochem. Mol. Biol., 193, 105426, 10.1016/j.jsbmb.2019.105426 · DOI
  70. D'Amelio, 2011, Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease, Nat. Neurosci., 14, 69, 10.1038/nn.2709 · DOI · Paper page
  71. Noble, 2009, Minocycline reduces the development of abnormal tau species in models of Alzheimer’s disease, FASEB J., 23, 739, 10.1096/fj.08-113795 · DOI
  72. Ragot, 2011, alpha-Tocopherol impairs 7-ketocholesterol-induced caspase-3-dependent apoptosis involving GSK-3 activation and Mcl-1 degradation on 158N murine oligodendrocytes, Chem. Phys. Lipids, 164, 469, 10.1016/j.chemphyslip.2011.04.014 · DOI
  73. Nakazawa, 2017, Effect of vitamin E on 24(S)-hydroxycholesterol-induced necroptosis-like cell death and apoptosis, J. Steroid Biochem. Mol. Biol., 169, 69, 10.1016/j.jsbmb.2016.03.003 · DOI
  74. Kim, 2017, Taxifolin reduces the cholesterol oxidation product-induced neuronal apoptosis by suppressing the Akt and NF-kappaB activation-mediated cell death, Brain Res. Bull., 134, 63, 10.1016/j.brainresbull.2017.07.008 · DOI
  75. DeKosky, 1990, Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity, Ann. Neurol., 27, 457, 10.1002/ana.410270502 · DOI · Paper page
  76. Crimins, 2013, The intersection of amyloid beta and tau in glutamatergic synaptic dysfunction and collapse in Alzheimer's disease, Ageing Res. Rev., 12, 757, 10.1016/j.arr.2013.03.002 · DOI

Cited by

Sorted by citations

Metadata

Authors
Staurenghi, E., Cerrato, V., Gamba, P., Testa, G., Giannelli, S., Leoni, V., Caccia, C., Buffo, A., Noble, W., Perez-Nievas, B. G., & Leonarduzzi, G.
ORCID
Venue
Redox Biology
Publisher
Elsevier BV
Published
2021-02
Volume
39
Pages
101837
ISSN
2213-2317
DOI
10.1016/j.redox.2020.101837
PMC
PMC7772793
Cited by
60
References
13
Language
en
Licence
Funders
Compagnia di San Paolo

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review